biotech
Cerus Corporation Announces Proposed Public Offering of Common Stock
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on February 28, 2006
cerus_logo.gif

Cerus Corporation announced plans to offer 4,500,000 shares of its common stock in an underwritten public offering.

Cerus' product pipeline include cancer therapy and immunotherapies for infectious diseases, including those that may be used for biodefense (anthrax and tularemia). Cerus also developed the INTERCEPT Blood System, which is designed to enhance the safety of donated blood components by inactivating viruses, bacteria, other pathogens and white blood cells.

For more investor information, refer to Cerus' website.

[Source: Cerus' press release]

Permalink: Cerus Corporation Announces Proposed Public Offering of Common Stock
Tags: stock  investment  biotech  cerus  common  common+stock  public+offering  cerus+corporation 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/16484
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Cerus Corporation Announces Proposed Public Offering of Common Stock:

  • Currently 6.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.50 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!